Overview Shionogi has launched Endeavorride, Japan’s first Software as a Medical Device (SaMD) digital therapeutic app for the adjunctive treatment of pediatric ADHD. The app, l...
Conversations Shaping Tomorrow's Healthcare
Overview Shionogi has launched Endeavorride, Japan’s first Software as a Medical Device (SaMD) digital therapeutic app for the adjunctive treatment of pediatric ADHD. The app, l...